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Purpose: Single nucleotide polymorphisms (SNPs) in the complement component 1 inhibitor (SERPING1) gene have
been shown to be significantly associated with age-related macular degeneration (AMD) in Caucasian populations. A
replication study of an association between these SNPs and AMD in a Chinese population is reported in this study.
Methods: Six SNPs, including rs2511990, rs1005510, rs11546660, rs2511989, rs2511988, and rs4926 in SERPING1
were genotyped in a Han Chinese subject group using the SNaPshot method of ABI. This subject group was composed
of 194 patients with choroidal neovascularization (CNV or wet) AMD, 78 patients with soft drusen, and 285 matched
controls. P values of the SNPs were calculated using an additive model. Haplotype frequencies between cases and controls
were compared by χ2 analysis. The haplotype analysis was performed using Haploview 4.0.
Results: None of the six SNPs showed significant association with AMD. None of the major haplotypes were observed
to be significantly associated with AMD or choroidal neovascularization AMD (CNV) after a stringent Bonferroni
correction.
Conclusions: We demonstrate that SNPs in SERPING1 are not significantly associated with AMD in the mainland Han
Chinese population.
Age-related macular degeneration (AMD) is a leading
cause of blindness in the elderly population, characterized as
chronic and progressive degeneration of photoreceptors, the
underlying  retinal  pigment  epithelium  (RPE),  Bruch’s
membrane, and possibly, the choriocapillaris in the macula
[1,2]. AMD is divided clinically into dry and wet AMD.
Patients with dry AMD present with cellular debris (drusen)
in or under the retinal pigment epithelium (RPE), irregularities
in the pigmentation of the RPE, or geographic atrophy (GA).
Patients with exudative or wet AMD are characterized by
serous detachment of the RPE or choroidal neovascularization
(CNV), or both [1,2]. Advanced AMD, including geographic
atrophy or exudative disease, can cause severe vision loss.
It is believed that AMD is a complex disorder caused by
the interaction of multiple genetic and environmental risk
factors [3–7]. Identification of AMD related genes has been
tremendously  successful.  Complement  pathway  genes,
including  complement  factor  H  (CFH)  [2,8–13],  C2/CFB
[14–16],  and  C3  [15–17],  have  been  confirmed  by  many
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replication studies. The LOC387715/HTRA1 gene has also
been verified as a major AMD locus in different populations
[18–24]. Recently, SNPs in the serpin peptidase inhibitor,
clade G (C1 inhibitor) member 1 (SERPING1) gene showed
highly  significant  genotypic  association  with  age-related
macular  degeneration  in  two  Caucasian  populations  [25].
Unfortunately, this finding could not be replicated by other
studies [26–34].
To further analyze the association of SERPING1 and
AMD, we investigated the association between SNPs in this
gene and AMD in a mainland Han Chinese population.
METHODS
Subjects: The Institutional Review Boards of the Sichuan
Provincial People’s Hospital, Xinhua Hospital of Shanghai
Jiao Tong University, and Zhongshan Ophthalmic Center,
China approved this study. All subjects provided informed
consent before participation in the study. AMD patients and
normal age-matched controls, including individuals with a
normal eye examination (individuals age 60 years or older
with  no  drusen  or  RPE  changes),  were  recruited  in  the
ophthalmology  clinic  at  Sichuan  Provincial  People’s
Hospital, Xinhua Hospital of Shanghai Jiao Tong University,
and Zhongshan Ophthalmic Center, China. All participants
went  through  a  standard  examination  protocol  as  in  the
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1previous  description  [19,24,27].  Grading  was  performed
using  a  standard  grid  classification  suggested  by  the
International ARM Epidemiological Study Group for age-
related  maculopathy  (ARM)  and  the  age-related  macular
degeneration group [27]. All abnormalities in the macula were
characterized  according  to  the  type,  size  and  number  of
drusen, and hyperpigmentation or hypopigmentation, as well
as AMD stages as defined by AREDS 1–5 stages. Patients
with clinical features of AMD and CNV (CNV from other
causes was excluded), with or without drusen, were diagnosed
as wet AMD patients. Patients with only soft drusen were
diagnosed as drusen (dry AMD) patients. In total, 194 wet
AMD patients (Eight from Zhongshan Ophthalmic Center, 28
from Xinhua Hospital, 158 from of the Sichuan Provincial
People’s Hospital), 78 soft drusen patients (all from of the
Sichuan  Provincial  People’s  Hospital),  and  285  normal
matched controls (Eight from Zhongshan Ophthalmic Center,
30  from  Xinhua  Hospital  and  247  from  of  the  Sichuan
Provincial People’s Hospital) were recruited. In the normal
matched controls, all individuals underwent an eye exam, no
signs  of  early  AMD,  such  as  soft  drusen  or  irregular
pigmentations of the RPE in the macular area, were observed.
Clinical information about the cases and controls is listed in
Table 1.
Selection of tag and functional SNPs: We used the data of the
Han  Chinese  Beijing  population  in  HapMap3  of  the
international HapMap project and previous studies to select
tag SNPs or functional SNPs in SERPING1 [26,28] for this
study.  Six  SNPs  were  selected  for  genotyping,  including
rs2511990  upstream  of  the  transcription  start  site  (−2877
bases), rs1005510 in intron 2, rs11546660 (A56V) in exon 3,
rs2511989, rs2511988 in intron 6, and rs4926 (M480V) in
exon 8.
Genotyping:  Blood  from  each  subject  was  drawn  and
collected in an EDTA-containing tube. Genomic DNA was
extracted from the blood by a Gentra Puregene Blood DNA
kit (Minneapolis, MN). SNP genotyping was performed by
the  dye  terminator-based  SNaPshot  method  (Applied
Biosystems, Foster City, CA). SNP analysis was performed
on  the  ABI  3130  genetic  analyzer  (Applied  Biosystems).
Genotypes  of  the  SNPs  were  determined  by  Genemapper
software (Applied Biosystems). All SNPs reported in this
manuscript had a genotyping success rate >96 percent and
accuracy as judged by random re-genotyping of 10 percent of
the samples in the subject group. Six SNPs in SERPING1 were
genotyped. The PCR and SNaPshot primers are listed in Table
2.
Haplotype analysis: Haplotype analysis was performed using
Haploview  4.0.  We  performed  the  haplotype  analysis
following the instructions from the Broad Institute. If the
genotype was not available, the genotype was set as 0.
Statistical analysis: Hardy–Weinberg equilibrium (HWE) for
each SNP polymorphism was tested by the χ2 test with df=1.
P values of the SNPs were calculated using an additive model.
Haplotype  frequencies  between  cases  and  controls  were
compared by χ2 analysis. The unadjusted odds ratios of the
alleles  and  genotypes  were  estimated  by  the  χ2  test.  All
statistical analyses were performed using the software SPSS,
(SPSS, Chicago, IL) version 10.0 [18–24].
RESULTS
Single  nucleotide  polymorphism  analysis:  All  six  SNPs
selected were successfully genotyped and all of these SNPs
were within HWE in both case (p>0.001, Table 3) and control
groups (p>0.05, Table 3). The SNP frequencies in this study
were similar to those of Han Chinese Beijing (HCB) available
TABLE 1. CHARACTERISTICS OF AMD CASES AND CONTROLS MATCHED FOR AGES AND ETHNICITY.
Subject Total number Male Female Average age
All AMD (CNV+drusen) 272 126 146 68.2±9.8
CNV 194 90 104 69.4±12.2
drusen 78 36 42 68.7±8.7
Controls 285 132 153 68.4±7.2
TABLE 2. GENOTYPING PRIMERS.
SNP PCR Primer Forward Snapshot Primer
rs2511989 F: TTCACAGCCTACCTTTCC CCCTGGGTTTAATACAGGGGTTGTCAACTC
  R: CAGCCTCAATCATAATACCA
rs2511990 F: AAGCTGGAGCTGAAACTG GTTCTCTTCCCACTGGGAGCAGGTCTAGGATTTCTC
  R: GGAAGAGGGATTCTGTGG
rs1005510 F: TTCTTACTACGAGGCACA ATGTGGAAAATGTCCTGTACAAGAGAGTAATTTCTGACAGTGC
  R: TAAATCAAGGAGCACAAG
rs2244169 F: TGGCGTGAACCCTGGAGA CAGCCAGAAAAGTTTTACAAAGCACGTATATGAC
  R: AGGTGGGAGGATTGCTTG
rs2511988 F: AGTGGGCTGGAACTTGGA ATTGTGGGAGAGCTGCAGCTGCCCCACCTAGAAAATAAGAGATGCA
  R: GCATTGTGACAGAGGGTG
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2in HapMap3 in the International HapMap Project. None of the
six  SNPs  showed  significant  association  with  AMD  or
subphenotypes of AMD including wet AMD or soft drusen,
which are landmarks of early AMD even before a stringent
Bonferroni correction (p≥0.05, Table 3). SNP rs2511989 was
reported to be the most significant association of SNP in the
SERPING1  gene  with  AMD  in  previous  studies  [25].
Although  rs2511989  showed  high  polymorphism,  no
association between this SNP and AMD was observed in the
Chinese population (p=0.76 for all AMD; p=0.61 for CNV
AMD; p=0.77 for soft drusen).
Haplotype  association  analysis:  We  then  performed
haplotype analysis using Haploview 4.0, and 14, 15, and 14
haplotypes were observed in the AMD-control, wet AMD-
control, and drusen-control groups, respectively. We found
that  haplotype  TGTGCG  and  haplotype  CGCGCG  were
shown to have a significant difference between both AMD-
control (p=0.0064, p=0.006, respectively, Table 4) and wet
AMD-control groups (p=0.0042, p=0.025, respectively, Table
4). The haplotype CGTGCG was shown to have a significant
difference between both AMD-control (p=0.0102, Table 4)
and  drusen-control  (p=0.032,  Table  4).  In  addition,  the
haplotype  CGTGTA  was  shown  to  have  a  significant
difference between wet AMD and controls (p=0.026, Table
4).  But  none  of  the  haplotypes  were  shown  to  have  a
significant difference between cases and controls (p>0.05,
Table 4) after a stringent Bonferroni correction. On the other
hand, the haplotype CGTGCA was shown to be significantly
associated  with  soft  drusen  in  our  subject  group
(p=7.87x10−5, Table 4) with frequencies of 0.11 in cases and
0.03 in controls, even after a stringent Bonferroni correction
(p=0.0011, Table 4). This haplotype conferred a 3.72-fold
(95% CI: 1.83–7.54) increased likelihood of dry AMD (Table
4). Additionally, the haplotype CGTACA was also shown to
have a significant difference between both all AMD-control
and  wet  AMD-control  groups  (p<0.05,  Table  4)  after  a
stringent Bonferroni correction. However, the frequency of
this haplotype was low and it was absent in the controls.
DISCUSSION
Although genes in complement pathways, including CFH,
C2/BF,  and  C3  [2,8–17]  and  chr.10q26  (LOC387715/
HTRA1) [18–24], have been identified as related to AMD,
these loci could not explain all genetic contributions to AMD,
suggesting that additional genetic variants related to AMD
have  not  yet  been  found.  Based  on  the  candidate  gene
approach, Ennis et al. [25] reported that SNPs in SERPING1
were significantly associated with AMD in two Caucasian
populations. Additional evidence for SERPING1 involving
AMD includes: 1) SERPING1 gene encoding C1INH plays an
TABLE 3. ASSOCIATION BETWEEN SUBPHENOTYPES OF AMD ANS SNPS IN SERPING1 IN THE HAN CHINESE SUBJECT GROUP.
SNP (risk allele)
Physical location





rs2511990 (T) 57119284 CVN+Drusen CC:211 CT:50 TT:10 0.13 0.003 0.59
   
CNV CC:148 CT:35 TT:10 0.14 0.002 0.3
   
Drusen CC:63 CT:15 TT:0 0.1 0.643 0.47
   
Control CC:226 CT:51 TT:8 0.12 0.068
rs1005510 (G) 57123798 CVN+Drusen AA:140 AG:117 GG:15 0.27 0.135 0.44
   
CNV AA:101 AG:81 GG:12 0.27 0.724 0.49
   
Drusen AA:39 AG:36 GG:3 0.27 0.312 0.58
   
Control AA:134 AG:131 GG:16 0.29 0.087
rs11546660 (C) 57124043 CVN+Drusen TT:249 CT:21 CC:0 0.04 0.506 0.05
   
CNV TT:178 CT:16 CC:0 0.04 0.836 0.1
   
Drusen TT:71 CT:5 CC:0 0.03 0.957 0.13
   
Control TT:245 CT:35 CC:1 0.07 0.978
rs2511989 (A) 57134901 CVN+Drusen GG:198 AG:57 AA:5 0.13 0.706 0.76
   
CNV GG:147 AG:42 AA:5 0.13 0.644 0.61
   
Drusen GG:51 AG:15 AA:0 0.08 0.298 0.77
   
Control GG:215 AG:63 AA:3 0.12 0.791
rs2511988 (C) 57135746 CVN+Drusen TT:155 CT:103 CC:14 0.25 0.557 0.99
   
CNV TT:110 CT:73 CC:11 0.24 0.971 0.89
   
Drusen TT:45 CT:30 CC:3 0.23 0.763 0.77
   
Control TT:155 CT:118 CC:9 0.24 0.025
rs4926 (A) 57138565 CVN+Drusen GG:201 AG:65 AA:6 0.14 0.784 0.43
   
CNV GG:147 AG:42 AA:5 0.13 0.644 0.7
   
Drusen GG:54 AG:23 AA:1 0.16 0.689 0.25
   
Control GG:209 AG:63 AA:3 0.13 0.766
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3important role in complement pathways, which have been
confirmed to participate in the pathogenesis of AMD; and 2)
SERPING1 was expressed in both retinal and RPE-choroid
layers in RT–PCR and immunofluorescence studies [25,29].
AMD  affection  status  was  correlated  with  increased
abundance of choroidal C1INH [29]. Complement activation
pathways include lectin, classical and alternative pathways.
SERPING1 encodes C1INH, an inhibitor of the classical and
lectin  pathways  of  complement  activation.  The  classical
complement pathway is initiated by the C1 complex, which
comprises a C1q hexamer complex with a zymogenic (C1r)2-
(C1s)  2).  SERPING1  irreversibly  inhibits  C1r  and  C1s,
MASP-1  (mannan-binding  lectin  serine  peptidase  1),  and
MASP-2 (mannan-binding lectin serine peptidase 2, the C1s
ortholog in the lectin pathway), as well as modulating the
complement  activation  through  inhibition  unrelated  to
proteases [30–33]. However, Park et al. [26] were unable to
replicate  the  association  between  the  genetic  variation  in
SERPING1 and AMD in two large and well characterized
Caucasian subject groups, and Allikmets et al. [34] were also
TABLE 4. SERPING1 HAPLOTYPE ASSOCIATION WITH AMD IN THE HAN CHINESE SUBJECT GROUP.






Odds ratio (95% CI)
    Case Control  
(p value)
 
All AMD H1:CATGTG 0.63 0.57 0.0609    
  H2:CGTGTG 0.04 0.06 0.1091    
  H3:TGTGCG 0.06 0.02 0.0064 0.0900  
  H4:TGTACG 0.03 0.04 0.3301    
  H5:CGTGCA 0.04 0.03 0.2641    
  H6:CGTGCG 0.02 0.05 0.0102 0.1428  
  H7:CATGTA 0.02 0.03 0.4105    
  H8:CATATG 0.02 0.03 0.5689    
  H9:TATGTG 0.02 0.01 0.3679    
  H10:CGCGCA 0.02 0.01 0.5900    
  H11:CGTACA 0.03 0.00 0.0008 0.0112  
  H12:CGTACG 0.01 0.02 0.4070    
  H13:CGTGTA 0.01 0.02 0.0628    
  H14:CGCGCG 0.00 0.02 0.0060 0.0840  
Wet AMD H1:CATGTG 0.63 0.57 0.0717    
  H2:CGTGTG 0.03 0.06 0.0946    
  H3:TGTACG 0.04 0.04 0.7668    
  H4:TGTGCG 0.06 0.02 0.0042 0.0630  
  H5:CGTGCG 0.02 0.05 0.0620    
  H6:CATGTA 0.03 0.03 0.6366    
  H7:CGTGCA 0.02 0.03 0.5447    
  H8:CATATG 0.02 0.03 0.2741    
  H9:CGCGCA 0.02 0.01 0.5848    
  H10:TATGTG 0.02 0.01 0.3616    
  H11:CGTACG 0.01 0.02 0.6028    
  H12:CGCGCG 0.00 0.02 0.0256 0.3840  
  H13:CGTACA 0.03 0.00 0.0003 0.0045  
  H14:CATGCG 0.01 0.01 0.3513    
  H15:CGTGTA 0.00 0.02 0.0263 0.3950  
Drusen AMD H1:CATGTG 0.62 0.57 0.2702    
  H2:CGTGTG 0.04 0.06 0.5894    
  H3:CGTGCA 0.11 0.03 7.87E-05 1.10E-03 3.72 (1.83–7.54)
  H4:CGTGCG 0.01 0.05 0.0317 0.4438  
  H5:TGTACG 0.01 0.04 0.0909    
  H6:CATATG 0.04 0.03 0.6489    
  H7:TGTGCG 0.05 0.02 0.1275    
  H8:CATGTA 0.02 0.03 0.3929    
  H9:CGTGTA 0.01 0.02 0.6998    
  H10:CGCGCG 0.00 0.02 0.0894    
  H11:TATGTG 0.02 0.01 0.3297    
  H12:CGCGCA 0.01 0.01 0.8976    
  H13:CGTACG 0.01 0.02 0.4630    
  H14:CATGCG 0.00 0.01 0.2656    
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4unable  to  replicate  the  association  between  rs2511989  in
SERPING1  and  AMD.  Additional  replication  studies,
especially of a different ethnicity, are important to determine
if SERPING1 is really associated with AMD. None of the six
SNPs showed significant association with AMD and none of
the  major  haplotypes  were  observed  to  be  significantly
associated with AMD or choroid neovascularization AMD
(CNV) after a stringent Bonferroni correction in our study,
suggesting that SERPING1 may not be related to AMD in the
Han Chinese population. In the haplotype analysis, none of
the SNPs tagged the significant haplotypes. Because half of
samples’ genotype data for rs11546660 and rs4926 was not
available in the HapMap3 for the Chinese, we cannot compare
the haplotype frequencies to those in the HapMap. Although
four haplotypes including TGTGCG, CGCGCG, CGTGCG,
and CGTGTA were shown to have significant associations
with  different  subphenotypes  of  AMD,  anymore  after  a
stringent Bonferroni correction, the significant associations
no longer existed, suggesting that these haplotypes were not
specifically  associated  with  AMD.  Since  the  haplotype
CGTACA was rare in all AMD (3%) and wet groups (3%),
and absent in the drusen group and controls, we think that the
significant association between this haplotype and AMD is
not  reliable.  The  haplotype  CGTGCA  was  shown  to  be
significantly associated with soft drusen in the subject group
even after a stringent Bonferroni correction (p=0.0011, Table
4). Further replication studies are needed to clarify the current
situation because of the limited number of soft drusen samples
in this study.
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